These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 9651880

  • 1. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
    Mugnaini M, Antolini M, Corsi M, van Amsterdam FT.
    J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
    [Abstract] [Full Text] [Related]

  • 2. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.
    Nowak G, Ossowska G, Jopek R, Papp M.
    Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723
    [Abstract] [Full Text] [Related]

  • 3. Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes.
    Mugnaini M, Dal Forno G, Corsi M, Bunnemann B.
    Eur J Pharmacol; 2000 Mar 17; 391(3):233-41. PubMed ID: 10729363
    [Abstract] [Full Text] [Related]

  • 4. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW.
    Mol Pharmacol; 1992 May 17; 41(5):914-22. PubMed ID: 1375317
    [Abstract] [Full Text] [Related]

  • 5. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
    Di Fabio R, Capelli AM, Conti N, Cugola A, Donati D, Feriani A, Gastaldi P, Gaviraghi G, Hewkin CT, Micheli F, Missio A, Mugnaini M, Pecunioso A, Quaglia AM, Ratti E, Rossi L, Tedesco G, Trist DG, Reggiani A.
    J Med Chem; 1997 Mar 14; 40(6):841-50. PubMed ID: 9083472
    [Abstract] [Full Text] [Related]

  • 6. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX, Kher SM, Zhou ZL, Ilyin V, Espitia SA, Tran M, Hawkinson JE, Woodward RM, Weber E, Keana JF.
    J Med Chem; 1997 Feb 28; 40(5):730-8. PubMed ID: 9057859
    [Abstract] [Full Text] [Related]

  • 7. Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
    Mugnaini M, Meoni P, Bunnemann B, Corsi M, Bowery NG.
    Br J Pharmacol; 2001 Apr 28; 132(8):1883-97. PubMed ID: 11309261
    [Abstract] [Full Text] [Related]

  • 8. Characterisation of [3H]MK-801 binding and its cooperative modulation by pig brain membranes.
    Höfner G, Wanner KT.
    J Recept Signal Transduct Res; 1996 Apr 28; 16(5-6):297-13. PubMed ID: 8968963
    [Abstract] [Full Text] [Related]

  • 9. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
    Baron BM, Siegel BW, Harrison BL, Gross RS, Hawes C, Towers P.
    J Pharmacol Exp Ther; 1996 Oct 28; 279(1):62-8. PubMed ID: 8858976
    [Abstract] [Full Text] [Related]

  • 10. Support for radiolabeling of a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex by 5,7-[3H]dichlorokynurenate in rat brain.
    Yoneda Y, Suzuki T, Ogita K, Han D.
    J Neurochem; 1993 Feb 28; 60(2):634-45. PubMed ID: 8419541
    [Abstract] [Full Text] [Related]

  • 11. [3H]5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites.
    Baron BM, Siegel BW, Slone AL, Harrison BL, Palfreyman MG, Hurt SD.
    Eur J Pharmacol; 1991 Feb 25; 206(2):149-54. PubMed ID: 1829684
    [Abstract] [Full Text] [Related]

  • 12. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM, Steele TD, Sharpe LG.
    J Pharmacol Exp Ther; 1997 Jan 25; 280(1):46-52. PubMed ID: 8996180
    [Abstract] [Full Text] [Related]

  • 13. Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex.
    Nowak G.
    Pol J Pharmacol; 1996 Jan 25; 48(2):137-43. PubMed ID: 9112643
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
    Grimwood S, Moseley AM, Carling RW, Leeson PD, Foster AC.
    Mol Pharmacol; 1992 May 25; 41(5):923-30. PubMed ID: 1375318
    [Abstract] [Full Text] [Related]

  • 15. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T, Marshall GR, Hill RG, Kemp JA.
    Br J Pharmacol; 1998 Aug 25; 124(8):1767-73. PubMed ID: 9756395
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX, Zhou ZL, Huang JC, Whittemore ER, Egbuwoku ZO, Lü Y, Hawkinson JE, Woodward RM, Weber E, Keana JF.
    J Med Chem; 1996 Aug 16; 39(17):3248-55. PubMed ID: 8765507
    [Abstract] [Full Text] [Related]

  • 17. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P, Sogliano C, Minei R, Tino A, Porcu P, Marino G, Tortiglione C, Concas A.
    Eur J Neurosci; 2004 Nov 16; 20(10):2598-604. PubMed ID: 15548203
    [Abstract] [Full Text] [Related]

  • 18. Use of [3H]5,7 dichlorokynurenic acid to identify strychnine-insensitive glycine receptors in human postmortem brain.
    Wamsley JK, Sofia RD, Faull RL, Ary T, Narang N, McCabe RT.
    Brain Res Bull; 1994 Nov 16; 35(3):205-9. PubMed ID: 7812798
    [Abstract] [Full Text] [Related]

  • 19. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E, Zapata A, Capdevila JL, Fossom LH, Skolnick P, Trullas R.
    J Pharmacol Exp Ther; 1998 May 16; 285(2):527-32. PubMed ID: 9580593
    [Abstract] [Full Text] [Related]

  • 20. A partial agonist model used in the allosteric modulation of the NMDA receptor.
    Robichon R, Randall PK, Leslie SW.
    Eur J Pharmacol; 1997 Jun 11; 328(2-3):255-63. PubMed ID: 9218709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.